The USC/Astrahan Plaque Experience

plus selected references which specifically mention Plaque Simulator (PDF files)

References
  • 1987
  • 1988
  • 1990
  • 1992
  • 1993
  • 1994
  • 1996
  • 1997
  • 2001
    • Knutsen, S., Hafslund, R., Monge, O.R., Valen, H., Muren, L.P., Rekstad, B.L., Krohn, J. and Dahl, O., Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy, International Journal of Radiation Oncology, Biology, Physics, 51: 1159-1166, 2001. (PDF)
    • Packer, K., Verification of ophthalmic brachytherapy treatment planning, Australian Physical & Engineering Sciences in Medicine 24:177-180, 2001.(PDF)
  • 2003
    • Astrahan, M.A., A patch source model for treatment planning of ruthenium ophthalmic applicators, Med. Phys., 30: 1219-1228, 2003. (PDF)
    • Krintz, A.L., Hanson, W.F., Ibbott, G.S. and Followill, D.S., A reanalysis of the collaborative ocular melanoma study medium tumor trial eye plaque dosimetry, International Journal of Radiation Oncology, Biology, Physics, 56: 889-898, 2003.
    • (PDF)
    • Nag, S., Quivey, J.M., Earle, J.D., Followill, D., Fontanesi, J. and Finger, P.T., The american brachytherapy society recommendations for brachytherapy of uveal melanomas, International Journal of Radiation Oncology, Biology, Physics, 56: 544-555, 2003. (PDF)
  • 2005
    • Astrahan, M., Improved treatment planning for COMS plaques, International Journal of Radiation Oncology, Biology, Physics,61(4):1227-1242, 2005.(PDF)
    • Astrahan, M., Szechter A and Finger P., Design and Dosimetric Considerations of a Modified COMS Plaque: The reusable seed-guide insert, Medical Physics,32(8), 2706-2716, 2005.(PDF)
  • 2009
    • Astrahan, M., Preplanning of Suture Coordinates for Episcleral Plaque Therapy, Medical Physics, Abstract SU-FF-T-74 36(6):2536, 2009.(PDF)
  • 2012
    • Marwaha, G., Wilkinson A., Bena, J., Macklis, R. and Singh, A.D., Dosimetric Benefit of a New Ophthalmic Radiation Plaque, International Journal of Radiation Oncology, Biology, Physics, 84(5): 1226-1230, 2012.(PDF)
    • Chiu-Tsao, S-T., Astrahan, M., Finger, P.T., Followill, D.S., Meigooni, A.S., Melhus, C.S., Mourtada, F., Napolitano, M.E., Nath, R., Rivard, M.J., Rogers, D.W.O and Thomson, R.M., Dosimetry of 125I and 103Pd COMS eye plaques for intraocular tumors: Report of Task Group 129 by the AAPM and ABS, Medical Physics, 39(10):6161-6184, 2012.(PDF)
  • 2013
    • Astrahan, M.A., The retina dose-area histogram: a metric for quantitatively comparing rival eye plaque treatment options, J Contemp Brachytherapy, 5(1): 23-32, 2013.(PDF)
    • Berry, J.L., Dandapani, S.V., Stevanovic, M., Lee, T.C., Astrahan, M.A., Murphree, A.L. and Kim, J.W, Outcomes of Choroidal Melanomas Treated With Eye Physics A 20-Year Review, JAMA Ophthalmology, 2013.(PDF)
  • 2015
    • Browne, A.W., Dandapani, S.V., Jennelle, R., Stevanovic, M., Lee, T.C., A. Murphree, A.L., Kampp, T.D., Astrahan, M.A., Kim, J.W, and Berry, J.L., Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling, Brachytherapy, 14(5):718-25, 2015.(PDF)
    • Berry, J.L., Kim, J.W., Jennelle, R. and Astrahan, M., Use of the Toric Surgical Marker to Aid in Intraoperative Plaque Placement for the USC Eye Physics Plaques to Treat uveal Melanoma: A New Surgical Technique, Ophthalmic Surg Lasers Imaging Retina, 46:866-870, 2015.(PDF)
  • 2018
    • Jennelle, R.L.S., Berry, J.L., Kim, J.W. (2018). Uveal Melanoma. In: Chang, E., Brown, P., Lo, S., Sahgal, A., Suh, J. (eds) Adult CNS Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-42878-9_17. (PDF)
    • Le, B.H.A., Kim, J.W., Deng, H., Rayess, N., Jennelle, R.L., hou, S.Y., Astrahan, M., and Berry, J.L., Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review, Brachytherapy, 17(6):981-989, 2018.(PDF)
  • 2019
  • 2020
    • Thomson, R.M., Furutani, K.M., Kaulich, T.W., Mourtada, F., Rivard, M.J., Soares, C.G., Vanneste, F.M. and Melhus, C.S., AAPM recommendations on medical physics practices for ocular plaque brachytherapy: Report of task group 221, Medical Physics, 47(5):e92-e124, 2020.(PDF)
    • Green, K., Toy, B., Ashimatey, B., Mustafi, D., Jennelle, R., Astrahan, M., Chu, Z., Wang, R., Kim, J., Berry, J., Kashani, A., Quantifying subclinical and longitudinal microvascular changes following episcleral plaque brachytherapy (EPB) using spectral-domain OCT angiography, Journal of VitreoRetinal Diseases, Aug. 2020.(PDF)
  • 2021
    • Fili, M., Astrahan, M., StÃ¥lhammar, D.A., Long-term outcomes after enucleation or plaque brachytherapy of choroidal melanomas touching the optic disc, Brachytherapy, ##(#)###, 2021.(PDF)
    • Joh, S., Kim M.E., Reilly, M., Zhou, S.Y., Kim J., Jennelle, R.L. and Berry, J.L., Outpatient ocular brachytherapy: The USC Experience, Advances in Radiation Oncology, 100737 (6)2021.(PDF)
    • Chevli, N., Schefler A.C., Bretana, M.E., Ramiro, P., Butler E.B. and Teh, B.S., Staged Eye-Plaque Brachytherapy: A Novel Approach for Large Uveal Melanoma, Advances in Radiation Oncology, 100712 (6)2021.(PDF)
  • 2022
    • Berkowitz, S.T., Brock, A.L., Astrahan, M.A., Reichstein, G., Annulus-shaped I-125 plaque brachytherapy for conjunctival melanoma, Amer. J. Ophth. Case Reports, 26(2022).(PDF)
  • 2023
    • Meltsner, S.G., Rodrigues, A., Materin, M.A., Kirsch, D.G and Craciunescu, O., Transitioning from a COMS-based plaque brachytherapy program to using eye physics plaques and plaque simulator treatment planning system: A single institutional experience, J Appl Clin Med Phys, https://doi.org/10.1002/acm2.13902, (2023).(PDF)